Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer — Stella

Home/Triple Negative Breast Cancer/DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer

View on ClinicalTrials.gov

Recruiting

Back to Triple Negative Breast Cancer trials

DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Moffitt Cancer Center, Tampa, Florida

Key details

Phase

Early testing

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

The Shulas' Foundation

Enrollment target

~30 participants

Started

August 2022

Primary completion

October 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.